Juan Naranjo

BiatGroup, Biotechnology Assets, is a Biotech Corporate Group devoted to Discover, Develop and Bring to the Market Next-Generation Solutions for Global Health: from Smart Vaccines to tailor made Immunotherapy Tools.

Contract Research Organization with offices in San Sebastian (Spain) and Cambridge (USA) offering more than 15 years of experience Zebrafish Services to Pharmaceutical, Biotech, Chemical, Cosmetic, and Nutraceutical companies. Our main aim is to accelerate our Clients R&D process minimizing risks through the zebrafish animal model, adding value to clients R&D&i mainly in preclinical toxicology, efficacy and disease models development. We are specialized in zebrafish working under Good Laboratory Practice (GLP) and thanks to our automated and innovative tools, we have developed and validated several fast and cost-effective Toxicity and Efficacy Assays, as well as disease models generation to be used in the preclinical stages. We are experts developing Tailor Made Solutions based on Client's requirements, such as models generation in different therapeutic areas, validation of diverse targets as well as customization of implemented assays. Biobide's Pipeline: - TARGET VALIDATION (with morpholinos) - DISEASE MODELS GENERATION - TOXICITY ASSAYS: Acutetox Assay, Teratox Assay, Cardiotox Assay, Hepatotox Assay, Behaviour Alteration's Assay, Ototox Assay, Immunotox Assay and Ecotox Assays - EFFICACY ASSAYS: Oncology (angiogenesis inhibition, tumoral models...), Central Nervous System (Alzheimer's Disease, Parkinson's Disease, Epilepsy, Neuroprotection...), Cardiovascular & Metabolism, Rare Diseases, Infectious Diseases... - TAILOR-MADE SOLUTIONS ---------- · Follow us on Twitter: https://twitter.com/biobide_ · "Like"​ our Facebook page: https://www.facebook.com/Biobide-1286387971453667/

ADL BioPharma’s experience in a leading position in the biopharmaceutical industry spans 6 decades. The company’s activity is mostly centred on two pivots: the development and production of active therapeutic substances (mainly beta-lactam active ingredients), and the development and manufacture on contract of products and intermediates obtained from fermentation processes for third parties in the food, cosmetic and biotechnology industries. What we offer The R&D, Quality and Production Units at ADL BioPharma offer comprehensive support for our customer’s projects, from the development of the process to its industrial scaling up, complying, upon demand, with the requirements established by the Good Manufacturing Practice system (GMP). We carry out projects that go from minimum amounts measured in grams to several tons, providing technical support throughout and in strict compliance with the applicable regulations.

Management programs for every stage of your career. Since 1958 developing leaders who wish to have a deep, positive and lasting impact on people, companies and society by leading with integrity, excellence and spirit of service.

GrayBella Capital is a London based Venture Capital fund, investing in fast-growth, deep technology and healthcare companies in Europe. We invest at Growth Stage, Series A and beyond.

Black Toro Capital is an investment firm focused on the rescue and stabilization of mid-sized companies in Spain. It invests throughout the capital structure with new capital injections and discounted securities purchases to deleverage and stabilize target company balance sheets. Investing across the balance sheet in mid-sized “good” companies with a viable and proven business model undergoing financial and liquidity constraints as well as lack of leadership controlled by traditional private owners or by financial institutions due to involuntary ownership.

BiatGroup, Biotechnology Assets, is a Biotech Corporate Group devoted to Discover, Develop and Bring to the Market Next-Generation Solutions for Global Health: from Smart Vaccines to tailor made Immunotherapy Tools.

Contract Research Organization with offices in San Sebastian (Spain) and Cambridge (USA) offering more than 15 years of experience Zebrafish Services to Pharmaceutical, Biotech, Chemical, Cosmetic, and Nutraceutical companies. Our main aim is to accelerate our Clients R&D process minimizing risks through the zebrafish animal model, adding value to clients R&D&i mainly in preclinical toxicology, efficacy and disease models development. We are specialized in zebrafish working under Good Laboratory Practice (GLP) and thanks to our automated and innovative tools, we have developed and validated several fast and cost-effective Toxicity and Efficacy Assays, as well as disease models generation to be used in the preclinical stages. We are experts developing Tailor Made Solutions based on Client's requirements, such as models generation in different therapeutic areas, validation of diverse targets as well as customization of implemented assays. Biobide's Pipeline: - TARGET VALIDATION (with morpholinos) - DISEASE MODELS GENERATION - TOXICITY ASSAYS: Acutetox Assay, Teratox Assay, Cardiotox Assay, Hepatotox Assay, Behaviour Alteration's Assay, Ototox Assay, Immunotox Assay and Ecotox Assays - EFFICACY ASSAYS: Oncology (angiogenesis inhibition, tumoral models...), Central Nervous System (Alzheimer's Disease, Parkinson's Disease, Epilepsy, Neuroprotection...), Cardiovascular & Metabolism, Rare Diseases, Infectious Diseases... - TAILOR-MADE SOLUTIONS ---------- · Follow us on Twitter: https://twitter.com/biobide_ · "Like"​ our Facebook page: https://www.facebook.com/Biobide-1286387971453667/